Regarding your thoughts on the manufacturing costs I have the exact same theory.
I have a suspicion there is more to Bioceuticals supply deal in that we could see in Blackmores also require material for a product in the very near future but it’s pure speculation on my part.
Ann: Appendix 4C Quarterly Activity and Cashflow Reports, page-35
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CCO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.22M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.8¢ | $67.05K | 8.299M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 6801568 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 241592 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| CCO (ASX) Chart |